Levomilnacipran Hydrochloride

CAS 175131-60-9 9 current records 1 historicalSmall Molecule

Who holds supplier records for Levomilnacipran Hydrochloride? 9 organisations hold a current record for Levomilnacipran Hydrochloride: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6), Italy (1), Spain (1) and China (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Levomilnacipran Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/levomilnacipran-hydrochloride

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Levomilnacipran Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Levomilnacipran Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Levomilnacipran Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Levomilnacipran Hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) used primarily as an antidepressant. It works by increasing the levels of serotonin and norepinephrine, neurotransmitters involved in regulating mood.

Chemical identity

IUPAC name
cis-(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride
Canonical SMILES
CCN(CC)C(=O)[C@]1(C[C@H]1CN)C2=CC=CC=C2.Cl
InChIKey
XNCDYJFPRPDERF-NQQJLSKUSA-N
Synonyms
Fetzima API, (1s,2r)-milnacipran hydrochloride, f 2695 hydrochloride, f-2695 hydrochloride, f2695 hydrochloride, fetzima, milnacipran hydrochloride, (1s,2r)-

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of action
Norepinephrine Uptake Inhibitors; Serotonin Uptake Inhibitors

Therapeutic areas

PsychiatryNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Levomilnacipran Hydrochloride?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Levomilnacipran Hydrochloride: CENTAUR PHARMACEUTICALS PVT LTD (India), COSMA SPA (Italy), Hetero Labs Limited (India), MICRO LABS LTD (India), MSN LIFE SCIENCES PRIVATE LIMITED (India), QUIMICA SINTETICA SA (Spain), RAKS PHARMA PVT LTD (India) and Zhejiang Huahai Pharmaceutical Co., Ltd. (China), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Levomilnacipran Hydrochloride Drug Master Files are active?

CENTAUR PHARMACEUTICALS PVT LTD (DMF 31699), COSMA SPA (DMF 31327), Hetero Labs Limited (DMF 33095), MICRO LABS LTD (DMF 29733), MSN LIFE SCIENCES PRIVATE LIMITED (DMF 30891), QUIMICA SINTETICA SA (DMF 31347), RAKS PHARMA PVT LTD (DMF 28015) and Zhejiang Huahai Pharmaceutical Co., Ltd. (DMF 29774) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Levomilnacipran Hydrochloride records mean?

1 organisation has only inactive Type II DMFs for Levomilnacipran Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Levomilnacipran Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Levomilnacipran Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.